Evidence map›Paper›PMID 35651701›Full record

ArticlePathology oncology research : POR2022

Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition

Ferenc Sipos, Bettina Bohusné Barta, Ágnes Simon, Lőrinc Nagy, Titanilla Dankó, Regina Eszter Raffay, Gábor Petővári, Viktória Zsiros, Barnabás Wichmann, Anna Sebestyén and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ferenc SiposDepartment of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Bettina Bohusné BartaDepartment of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Ágnes SimonDepartment of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Lőrinc NagyDepartment of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Titanilla DankóDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Regina Eszter RaffayDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Gábor PetőváriDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Viktória ZsirosDepartment of Anatomy, Histology and Embryology, Semmelweis University, Budapest, Hungary.
Barnabás WichmannLufthansa Systems Hungária, Budapest, Hungary.
Anna SebestyénDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Györgyi MűzesDepartment of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Semmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colonic NeoplasmsToll-Like Receptor 9AutophagyChloroquineDNA, NeoplasmHT29 CellsHumansReceptor, IGF Type 1ChloroquineDNA, NeoplasmIGF1R protein, humanReceptor, IGF Type 1TLR9 protein, humanToll-Like Receptor 9autophagyCD133HT29 cancer cellIGF1Rself-DNATLR9

Identifiers

PMID35651701
PMCPMC9148969
OpenAlexW4280522188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.